Cargando…

Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand

Detalles Bibliográficos
Autores principales:	Deerochanawong, Chaicharn, Krittayaphong, Rungroj, Romano, Jack Garcia Uranga, Rhee, Nicolai A., Permsuwan, Unchalee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126194/ https://www.ncbi.nlm.nih.gov/pubmed/37000391 http://dx.doi.org/10.1007/s13300-023-01392-7

Ejemplares similares

Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2023)

Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
por: Vareesangthip, Kriengsak, et al.
Publicado: (2022)

Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2019)

Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Cost–Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
por: Krittayaphong, Rungroj, et al.
Publicado: (2019)

Treatment Costs for Patients with Chronic Kidney Disease Who Received Multidisciplinary Care in a District Hospital in Thailand
por: Songsermlosakul, Suwaporn, et al.
Publicado: (2020)

Economic Burdens of Type 2 Diabetes Hospital Visits with Hypoglycemic Episodes in the Tertiary Care Setting in Thailand
por: Kosachunhanun, Natapong, et al.
Publicado: (2023)

Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand
por: Permsuwan, Unchalee, et al.
Publicado: (2020)

Diabetes management in Thailand: a literature review of the burden, costs, and outcomes
por: Deerochanawong, Chaicharn, et al.
Publicado: (2013)

Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand
por: Yamwong, Sukit, et al.
Publicado: (2014)

Economic Burdens for Treatment of Patients With Type 2 Diabetes in North Thailand: A Hospital-Based Observational Study
por: Phrommintikul, Arintaya, et al.
Publicado: (2022)

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
por: Permsuwan, Unchalee, et al.
Publicado: (2016)

Discounting money and health effects from communicable and noncommunicable diseases in Thailand
por: Yadee, Jirawit, et al.
Publicado: (2023)

Characterization of hypersensitivity reactions reported among Andrographis paniculata users in Thailand using Health Product Vigilance Center (HPVC) database
por: Suwankesawong, Wimon, et al.
Publicado: (2014)

Cost–Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in Thailand
por: Permsuwan, Unchalee, et al.
Publicado: (2022)

National trend in heart failure hospitalization and outcome under public health insurance system in Thailand 2008–2013
por: Janwanishstaporn, Satit, et al.
Publicado: (2022)

Prevalence and Associated Factors for Thyroid Dysfunction Among Patients On Targeted Therapy for Cancers: A Single-Center Study from Thailand
por: Chawalitmongkol, Korawan, et al.
Publicado: (2023)

Basal Insulin Dose Titration for Glycemic Control in Patients With Type 2 Diabetes Mellitus in Thailand: Results of the REWARDS Real-World Study
por: Deerochanawong, Chaicharn, et al.
Publicado: (2020)

An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care for Treatment of Moderate COVID-19 in Thailand
por: Sarojvisut, Phahol, et al.
Publicado: (2023)

Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
por: Winijkul, Arjbordin, et al.
Publicado: (2021)

Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland
por: Stawowczyk, Ewa, et al.
Publicado: (2016)

Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials
por: Sriuttha, Pajaree, et al.
Publicado: (2018)

Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
por: AlQahtani, Manaf, et al.
Publicado: (2022)

Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials
por: Amani, Bahman, et al.
Publicado: (2021)

Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
por: Graham, Jonathan, et al.
Publicado: (2016)

Comparing CenteringPregnancy® to standard prenatal care plus prenatal education
por: Benediktsson, Ingunn, et al.
Publicado: (2013)

Author Correction: Life cycle assessment of maize cultivation and biomass utilization in northern Thailand
por: Supasri, Titaporn, et al.
Publicado: (2021)

Acupuncture or cupping plus standard care versus standard care in moderate to severe COVID-19 patients: An assessor-blinded, randomized, controlled trial
por: Alipour, Reihane, et al.
Publicado: (2022)

A randomised, pragmatic clinical trial of ACUpuncture plus standard care versus standard care alone FOr Chemotherapy Induced peripheral Neuropathy (ACUFOCIN)
por: Stringer, Jacqui, et al.
Publicado: (2022)

Prevalence of chronic kidney disease associated with cardiac and vascular complications in hypertensive patients: a multicenter, nation-wide study in Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2017)

ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
por: Flood, Michael P., et al.
Publicado: (2022)

Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial
por: Solanich, Xavier, et al.
Publicado: (2021)

Reply to “‘Tolerance’ of Misused Terminology? Enforcing Standardized Phenotypic Definitions”
por: Haaber, Jakob, et al.
Publicado: (2015)

The rate of patients at high risk for cardiovascular disease with an optimal low-density cholesterol level: a multicenter study from Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2019)

Optimal INR level for warfarin therapy after mechanical mitral valve replacement
por: Kamthornthanakarn, Itthidet, et al.
Publicado: (2019)

Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome
por: Towashiraporn, Korakoth, et al.
Publicado: (2022)

Impact of different degrees of left ventricular strain on left atrial mechanics in heart failure with preserved ejection fraction
por: Songsangjinda, Thammarak, et al.
Publicado: (2022)

Silk garments plus standard care compared with standard care for treating eczema in children: A randomised, controlled, observer-blind, pragmatic trial (CLOTHES Trial)
por: Thomas, Kim S., et al.
Publicado: (2017)

Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model
por: Reynolds, Matthew R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_49rhme55aplk6c2apmqe588f39